Thursday, January 21, 2010
Update in Pediatric Oncology
Article title: Update in Pediatric Oncology
Author(s): Dunn, Nancy et al.
Journal: Pediatric Oncology
Page #s: pp. 10-19
Year: 1990
Major topic: Pediatric Dentistry
Minor topic(s): None
Type of Article: Topic Summary
Main Purpose: Fortunately, the outlook for children with cancer is improving. This article gives a brief overview of current
Overview of method of research: NA
Key points in the article discussion:
I. Intro:
A. Childhood cancer is still very rare and 85% are either hematological, sarcomas or embryonal tumors (85% of adult cancers are carcinomas). Despite this, it is still the leading cause of death from disease in children under 15y.o. Now, death rate is actually less than half of what it was in 1950.
B. Most children diagnosed with cancer are referred to treatment centers where they are cared for by multi-disciplinary teams. This concentration of care and knowledge has led to massive advancements in knowledge, prognosis indicators and supportive care techniques.
II. Advances in Dx and Tx modalities
A. Tumor Biology
1. Collaborative study participation has lead to numerous histological comparisons, discoveries and prognostic indicator progress.
B. Prognostic Indicators
1. Relatively new phenomena. There were none when no one survived their disease. As more and more children survived, it became apparent that some did better than others. We can now more safely group patients into prognostic risk groups based on these prognostic indicators. Also allows therapy to be more individual.
C. Supportive Care
1. New recommendations WRT to SBE prophylaxis have been developed based on observations and therapies administered to these large groups of kids.
D. Newer Therapeutic Concepts
1. Lately, the interrelationship between surgical, radiation and chemotherapy has been changing. There aren’t many cancers that can be completely removed surgically. Also, early radiation treatment has been playing a smaller role. Chemotherapy is becoming more of the mainstay of treatment in pediatric Pt’s. Bone marrow transplants have become a 4th and commonly used method of treatment.
III. Pediatric Malignancies
A. ALL: 75-80% of childhood leukemias. Most common single malignancy in children. More common in White males age 3-5. Etiology unknown, many theories. Siblings at greater risk and children of parents with chromosomal abnormalities and immunocompromised states at greater risk. Fatigue, bone pain, fever, weight loss, bleeding, pallor, pymphadenopathy or asymptomatic.
1. Dx. made by >25% lymphoblasts in bone marrow.
2. Chemotherapy has provided >95% remission. Overall chance of >5 yr, event-free survival is approx 60%.
3. Usually any bone marrow relapse withing 6 mo. of chemo is sign of poor prognosis.
B. ANLL: 15-20% of leukemias in children. Similar to ALL. But not typically presenting with lymphadenopathy. Gingival hyperplasia more common.
1. Similar treatment to ALL: aggressive chemo, supportive care and CNS prophylaxis. >5yr event-free survival 25-45%. With chemo, up to 60% with bone marrow transplant.
C. CML: Rare in childhood representing <5%>
Assessment of article: Bottom line... too much information to summarize effectively. I barely skimmed the surface and omitted TONS. Maybe someone should call shenanigans on ME.
Micrognathia after radiation therapy for childhood facial tumors
Department of Pediatric Dentistry
Lutheran Medical Center
Date: 01/22/2010
Article title: Micrognathia after radiation therapy for childhood facial tumors
Author(s): Kaste SC, Hopkins KP
Journal: Oral Surg Oral Med Oral Path
Volume (number): 77:95-99
Month, Year: 1994
Major topic: Affect of radiation therapy on oral structures
Minor topics: Dental management of pts under radiation therapy
Type of Article: 2 cases and long-term follow-up
Main Purpose: Educate readers on the consequences of radiation therapy
Overview of method of research: Review of current treatment modalities and case review
Findings: Radiation-induced dental effects include maxillary and mandibular hypoplasia, tooth or root dwarifsm, anodontia, caries and altered tooth eruption patterns. Additionally, radiation causes osteocyte death, microvascualr injury, periosteal damage and fibrous replacement of marrow spaces with all affect bone growth and development. The impact and severity of these treatments are depend on the child’s age at time of therapy, the radiation dose, and anatomical location of treatment.
Radiation doses of 10Gy and 30Gy have been shown to permanently damage ameloblasts. And studies have shown that does in excess of 20 Gy can result in significant bone and growth disturbance, regardless of age. It is particularly damaging if therapy in done during times of significant patient growth.
Knowing the late effects of radiation treatment to oral (or near oral) structures can aid clinicians in anticipatory guidance and help them better manage patients and improve their quality of life.
Key points/Summary :
Case 1:
4yr old boy with an extra-abdominal desmoid tumor on the palate. He received 32 Gy in addition to chemotherapy. Lateral Ceph at the time of treatment revealed a “normal” skeletal relationship of the maxilla and mandible.
At age 6, mandiblar lysis, root agenesis and stunting of root development of radiographically evident.
At age 12, radiographs revealed over-retained primary teeth, and displaced permanent molars. Significant mandibular micrognathia was present and overjet with severe.
At age 17 micrognathia was apparent and microdontia of all permanent 2nd molars was present. The crowns of the 3rd molars were displaced high in the ramus.
Case 2:
5 year old with embryonal rhabdomyosarcoma arising in the right nasopharynx. Threated with 35Gy and chemotherapy.
At age 15 he showed generalized root stunting, malposition of maxillary teeth and significant maxillary hypoplasia with facial disproportion. Some anodontia was also present.
Assessment of article: Very interesting. This would be a very interesting and challenging population to treat. The article never addressed what, if any, dental treatment was offered to these patients. That would be interesting to know, since the article suggested that dentists could improve the patient quality of life through proper management.
Recognizing Cancer in Children 01/22/2010
Date: 01/22/2010
Article title: Recognizing Cancer in Children
Author(s): William H. Schultz
Journal: Journal of the American Academy of Physician Assistants
Volume #2; Number 5; Pg 338-352
Year: 1989
Major topic: Cancer in children
Type of Article: Review of current information
Main Purpose:
Increase the practitioner’s awareness of childhood cancer to aid in better diagnosis
Overview of method of research: Review of current information
Background and discussion:
An estimated 6500 cancers are diagnosed each yr in children, most common of which are leukemia, lymphomas, or brain tumors.
Etiology: Common cancers in children involve tissues that are not in direct contact with the environment. Genetic predisposition is more important in causing cancer in children than are environmental agents. (Table 1) Disorders with preexisting chromosomal aberrations, such as Down syndrome and Bloom syndrome, are associated with a high risk of leukemia. Also, a few childhood cancers are inherited such as retinoblastoma.
Diagnosis: The clinical features of childhood cancer are not obvious because signs and symptoms are usually nonspecific. Diagnosis is often delayed because major complaints are usually attributed to minor causes. Lymph node enlargement, fever, weakness, weight loss, cough, and shortness of breath are common symptoms associated with infectious diseases but are also cardinal features of malignancies. (Table 2) Even though most pediatric tumors have already metastasized before diagnosis, early detection of an asymptomatic tumor enhances the child’s prognosis.
Management: Emotional support for family should be provided. Children treated at pediatric cancer centers with state of the art protocols have a higher disease free survival rate than do children treated elsewhere. Supportive care must be provided to manage the acute complications of aggressive cancer therapy. These may include erythrocyte/platelet transfusion and broad spectrum antibiotics. Infections are the leading cause of death in children with cancer. Patients undergoing cancer therapy should not be vaccinated with live virus preparations.
Common Childhood Malignancies:
1. Acute Leukemia: Hematologic malignancies including leukemia and lymphomas, comprise the majority of cancers seen in children. Leukemia arises in the bone marrow and is a cancer of the leukocytes and progresses to bone marrow dysfunction and infiltration of tissues. A triad of anemia, neutropenia, and thrombocytopenia is a common consequence of dysfunctional bone marrow. Hematologic manifestations of leukemia are due to bone marrow replacement with malignant cells. Significant bone pain results when the marrow cavity becomes packed with leukemic cells. (Table 3) Erythrocyte mass and oxygen carrying capacity of the blood is decreased resulting in fatigue, irritability, pallor, tachycardia, and dyspnea. Acute lymphocytic leukemia is the most prevalent childhood leukemia. Bone marrow aspiration is the definitive test for leukemia. Before starting therapy a spinal tap is done to determine any CNS involvement. Most protocols call for 3 years of therapy. Bone marrow transplant may be required during therapy.
2. Brain Tumors: CNS tumors are the second most common childhood cancer. The clinical features of most childhood brain tumors are due to increased intracranial pressure caused by spinal fluid obstruction. (Table 4) Older children may have history of morning headache, vomiting, dizziness, or change in behavior. CT scan and MRI are the most specific tests to determine intracranial neoplasm. Surgical resection and irradiation therapy are the treatment for childhood brain tumors.
3. Lymphomas: Lymphomas are a diverse group of cancers of the immune system. Included in this group of lymphoid cancers are Hodgkin’s disease (HD) and non-Hodgkin’s lymphoma (NHL). Progressive cervical lymph node enlargement without associated symptoms is the most common early clinical manifestation of HD in children. Painless hard lymph nodes frequently represent metastatic cancer. In NHL, the gastrointestinal tract and mediastinum are primary disease sites more often than peripheral lymph nodes. Diagnosis of lymphoma is based upon histologic examination of involved tissues. Treatment of localized, early stage HD may consist of radiation alone but more advanced disease may require either involved-field or extended-field radiation combined with multiagent chemotherapy. NHL must be regarded as microscopically disseminated at diagnosis and always requires chemotherapy. The diagnosis for children with abdominal tumors is more favorable when complete excision is possible.
4. Neuroblastoma (Nb): Arises from neural crest tissues of the sympathetic nervous system and demonstrates a diversity of primary sites from the base of the skull to deep in the pelvis. Most occur in the retroperitoneal area. Nb is the most frequently discovered malignant tumor in infants. Children diagnoses after the age of 2 do much worse than those who are younger at diagnosis. Nb frequently causes nonspecific symptoms that sometimes mimic common pediatric illnesses. Vanillylmandelic acid and homovanillic acid are metabolites whose levels are elevated in Nb and can be easily measured in the urine for diagnostic purposes. Total surgical excision of localized tumor can achieve a 2 year survival rate greater than 80%. Unfortunately most Nb is widespread at diagnosis. Post operative chemotherapy and irradiation may shrink an unresectable tumor.
5. Wilms’ Tumor (WT): Is a primary malignancy of mixed histologic features occurring in the kidney. It is the most common abdominal neoplasm in children. WT is often discovered when the child’s abdomen enlarges or an abdominal mass is found. Symptoms include malaise, constipation, anorexia, or fever. It is usually palpated unilaterally but a small percentage of cases involve both kidneys. Treatment protocol may include radiotherapy, adjunctive chemotherapy, or surgical nephrectomy depending on staging.
6. Osteosarcoma (Os): Is a relatively rare bone cancer that affects adolescents. The tumor usually arises in the long bones in the metaphyseal region, where growth is more active. The femur, tibia and humerus are frequent sites of primary tumor involvement, with most originating around the knee. A Common symptom of Os is pain and swelling at the primary site. Histologic examination of tissue obtained with an open biopsy confirms the diagnosis. With the ability to identify intramedullary tumor extension, more conservative surgical approaches can be tried, such as cross-bone amputations and “limb sparing” procedures. Adjunctive chemotherapy for Os is a common treatment protocol.
Fortunately, cancer in children is rare. Early diagnosis and appropriate referral is so important and may greatly improve prognosis.
Assessment of article:
Good article. May be a little outdated at 21 years old but still relevant to the pediatric dentist who should have some knowledge of the cancer types that commonly affect our patient population.